Health Canada’s approval recognises Nutriterra’s ability to support heart and brain health and provides a new option to meet the growing demand for plant-based total omega-3 with DHA, EPA, and…

Health Canada’s approval recognises Nutriterra’s ability to support heart and brain health and provides a new option to meet the growing demand for plant-based total omega-3 with DHA, EPA, and ALA

Nutriterra Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorises it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims:

Supports heart health and cardiovascular function

Supports normal brain function

Source of docosahexaenoic acid (DHA) for maintaining good health

Source of alpha-linolenic acid (ALA) for maintaining good health

Source of an essential fatty acid for the maintenance of good health

Source of omega-3 fatty acids for the maintenance of good health

Nufarm Nutritional general manager, Benita Boettner, said today’s announcement from NNHPD confirms the nutritional importance of Nutriterra Total Omega-3 Canola oil. “Health Canada’s approval recognises Nutriterra’s ability to support heart and brain health and provides a new option to meet the growing demand for plant-based total omega-3 with DHA, EPA, and ALA.”

Human clinical trials confirmed that Nutriterra’s long-chain fatty acids are readily incorporated into blood lipids. Results were reviewed and authorised by NNHPD and published in Frontiers in Nutrition in 2022. A 2000 mg/day serving of Nutriterra significantly improved indicators of omega-3 status, including the OmegaScore and the Omega-3 Index, both of which are supportive of cardiovascular and brain health.